===== phenotype 39=================================================================proportion of pts: 0.161047203491lambda: 6462.33764389--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNARodenticidesSodium Potassium Chloride Symporter InhibitorsVasodilator Agents===== phenotype 19=================================================================proportion of pts: 0.144387147957lambda: 5259.01963412--------------------------------------------------------------------------------Anti-Allergic AgentsAnti-Bacterial AgentsAnti-Inflammatory AgentsGABA ModulatorsGlucocorticoidsHistamine H1 Antagonists, Non-SedatingImmunosuppressive AgentsNA===== phenotype 28=================================================================proportion of pts: 0.165410551369lambda: 5109.31355372--------------------------------------------------------------------------------Anti-Allergic AgentsCyclooxygenase InhibitorsHistamine H1 Antagonists, Non-SedatingHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump Inhibitors===== phenotype 32=================================================================proportion of pts: 0.149940499802lambda: 5045.68046504--------------------------------------------------------------------------------Adrenergic beta-2 Receptor AgonistsAnalgesics, Non-NarcoticAnti-Allergic AgentsAnti-Bacterial AgentsAntimanic AgentsHistamine H1 Antagonists, Non-SedatingNA===== phenotype 38=================================================================proportion of pts: 0.132090440301lambda: 4953.63635433--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsAngiotensin II Type 1 Receptor BlockersAntimanic AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNA===== phenotype 23=================================================================proportion of pts: 0.174137247124lambda: 4831.2038782--------------------------------------------------------------------------------Bone Density Conservation AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNAVasodilator Agents===== phenotype 42=================================================================proportion of pts: 0.126537088457lambda: 4558.4225724--------------------------------------------------------------------------------Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingNASodium Potassium Chloride Symporter InhibitorsSurface-Active AgentsVasodilator AgentsVitamin B Complex===== phenotype 8=================================================================proportion of pts: 0.142800476002lambda: 4356.33089178--------------------------------------------------------------------------------Cyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNAProton Pump Inhibitors===== phenotype 37=================================================================proportion of pts: 0.12177707259lambda: 4307.60118896--------------------------------------------------------------------------------Analgesics, Non-NarcoticAnti-Bacterial AgentsAntidepressive Agents, Second-GenerationCatharticsNANarcoticsProton Pump InhibitorsSurface-Active Agents===== phenotype 49=================================================================proportion of pts: 0.134073780246lambda: 3937.9240192--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsExplosive AgentsGABA ModulatorsNitric Oxide DonorsPurinergic P2Y Receptor Antagonists===== phenotype 17=================================================================proportion of pts: 0.140023800079lambda: 3816.70902973--------------------------------------------------------------------------------Anti-Bacterial AgentsCardiotonic AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNA===== phenotype 33=================================================================proportion of pts: 0.13248710829lambda: 3697.23061276--------------------------------------------------------------------------------Anti-Allergic AgentsAntihypertensive AgentsBone Density Conservation AgentsCyclooxygenase InhibitorsNA===== phenotype 45=================================================================proportion of pts: 0.11820706069lambda: 3638.57530574--------------------------------------------------------------------------------Anti-Allergic AgentsAntihypertensive AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNAVasodilator Agents===== phenotype 48=================================================================proportion of pts: 0.119793732646lambda: 3606.20789456--------------------------------------------------------------------------------Anti-Allergic AgentsBone Density Conservation AgentsCyclooxygenase InhibitorsNAProton Pump InhibitorsVasodilator Agents===== phenotype 47=================================================================proportion of pts: 0.117413724712lambda: 3566.36582956--------------------------------------------------------------------------------Analgesics, Non-NarcoticBone Density Conservation AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNANarcoticsVoltage-Gated Sodium Channel Blockers===== phenotype 2=================================================================proportion of pts: 0.118603728679lambda: 3398.50914925--------------------------------------------------------------------------------Adrenergic alpha-1 Receptor AntagonistsAngiotensin II Type 1 Receptor BlockersCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNA===== phenotype 11=================================================================proportion of pts: 0.143990479968lambda: 3272.96421281--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump InhibitorsVasodilator Agents===== phenotype 12=================================================================proportion of pts: 0.11463704879lambda: 3230.66456297--------------------------------------------------------------------------------Analgesics, Non-NarcoticBone Density Conservation AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump InhibitorsVasodilator Agents===== phenotype 1=================================================================proportion of pts: 0.134073780246lambda: 3073.99907454--------------------------------------------------------------------------------Antineoplastic Agents, HormonalBone Density Conservation AgentsDopamine Uptake InhibitorsEnzyme InhibitorsNucleic Acid Synthesis InhibitorsVitamin B ComplexVoltage-Gated Sodium Channel Blockers===== phenotype 25=================================================================proportion of pts: 0.103133677112lambda: 2991.88614262--------------------------------------------------------------------------------Analgesics, Non-NarcoticAnti-Anxiety AgentsAnti-Bacterial AgentsNANarcoticsSurface-Active Agents===== phenotype 30=================================================================proportion of pts: 0.122570408568lambda: 2976.17307712--------------------------------------------------------------------------------Adrenergic alpha-1 Receptor AntagonistsFree Radical ScavengersNAProton Pump InhibitorsSodium Potassium Chloride Symporter InhibitorsTubulin ModulatorsVasodilator Agents===== phenotype 16=================================================================proportion of pts: 0.145180483935lambda: 2918.59932503--------------------------------------------------------------------------------Cyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump InhibitorsTopoisomerase II InhibitorsVasodilator Agents===== phenotype 36=================================================================proportion of pts: 0.122173740579lambda: 2878.68916721--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsCardiotonic AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNATopoisomerase II InhibitorsVasodilator Agents===== phenotype 46=================================================================proportion of pts: 0.120983736612lambda: 2843.32818421--------------------------------------------------------------------------------Antidepressive Agents, Second-GenerationCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAVasodilator Agents===== phenotype 34=================================================================proportion of pts: 0.115033716779lambda: 2799.22591878--------------------------------------------------------------------------------AntioxidantsBone Density Conservation AgentsCyclooxygenase InhibitorsGABA-A Receptor AgonistsHydroxymethylglutaryl-CoA Reductase InhibitorsNAVitamin B Complex===== phenotype 13=================================================================proportion of pts: 0.127727092424lambda: 2751.41328637--------------------------------------------------------------------------------Analgesics, Non-NarcoticCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump InhibitorsVasodilator Agents===== phenotype 0=================================================================proportion of pts: 0.12534708449lambda: 2698.25940575--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsAnalgesics, Non-NarcoticAnti-Allergic AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump Inhibitors===== phenotype 24=================================================================proportion of pts: 0.0900436334788lambda: 2689.91072175--------------------------------------------------------------------------------Anti-Bacterial AgentsAntidepressive Agents, Second-GenerationAntimanic AgentsDopamine Uptake InhibitorsGABA ModulatorsProton Pump InhibitorsVoltage-Gated Sodium Channel Blockers===== phenotype 5=================================================================proportion of pts: 0.132090440301lambda: 2629.51216556--------------------------------------------------------------------------------Cyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAProton Pump Inhibitors===== phenotype 29=================================================================proportion of pts: 0.11463704879lambda: 2606.1384319--------------------------------------------------------------------------------Adrenergic alpha-1 Receptor AntagonistsAndrogensCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAPhosphodiesterase 5 InhibitorsVasodilator Agents===== phenotype 9=================================================================proportion of pts: 0.112653708846lambda: 2481.30137795--------------------------------------------------------------------------------Anti-Allergic AgentsAntidepressive Agents, Second-GenerationCyclooxygenase InhibitorsHistamine H1 Antagonists, Non-SedatingHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 35=================================================================proportion of pts: 0.120190400635lambda: 2383.36170359--------------------------------------------------------------------------------Antihypertensive AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAVitamins===== phenotype 18=================================================================proportion of pts: 0.121380404601lambda: 2340.08604363--------------------------------------------------------------------------------Anti-Allergic AgentsCyclooxygenase InhibitorsGABA-A Receptor AgonistsHypoglycemic AgentsNANarcoticsProton Pump Inhibitors===== phenotype 15=================================================================proportion of pts: 0.126140420468lambda: 2296.25793568--------------------------------------------------------------------------------Cyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNAVasodilator Agents===== phenotype 40=================================================================proportion of pts: 0.12534708449lambda: 2206.51798269--------------------------------------------------------------------------------Bone Density Conservation AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 10=================================================================proportion of pts: 0.0955969853233lambda: 2189.11303523--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsAnticholesteremic AgentsBone Density Conservation AgentsCyclooxygenase InhibitorsNAProton Pump InhibitorsVasodilator Agents===== phenotype 14=================================================================proportion of pts: 0.13248710829lambda: 2153.42513356--------------------------------------------------------------------------------Cyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNASodium Chloride Symporter Inhibitors===== phenotype 6=================================================================proportion of pts: 0.0924236414121lambda: 2116.74978638--------------------------------------------------------------------------------Anti-Allergic AgentsBone Density Conservation AgentsGABA ModulatorsHistamine H1 Antagonists, Non-SedatingNAProton Pump InhibitorsVitamin B Complex===== phenotype 20=================================================================proportion of pts: 0.0963903213011lambda: 2018.3953337--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsNANootropic AgentsSodium Potassium Chloride Symporter Inhibitors===== phenotype 43=================================================================proportion of pts: 0.117017056724lambda: 2010.06803293--------------------------------------------------------------------------------Adrenergic beta-2 Receptor AgonistsAnti-Bacterial AgentsAntineoplastic Agents, Hormonal===== phenotype 44=================================================================proportion of pts: 0.105117017057lambda: 1962.71559475--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsAnalgesics, Non-NarcoticAnti-Bacterial AgentsBone Density Conservation AgentsNATopoisomerase II Inhibitors===== phenotype 26=================================================================proportion of pts: 0.104323681079lambda: 1951.84336922--------------------------------------------------------------------------------Analgesics, Non-NarcoticAnti-Bacterial AgentsNAProton Pump Inhibitors===== phenotype 27=================================================================proportion of pts: 0.102340341134lambda: 1864.22794491--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 21=================================================================proportion of pts: 0.136850456168lambda: 1807.19649717--------------------------------------------------------------------------------Angiotensin II Type 1 Receptor BlockersAntidepressive Agents, Second-GenerationAntihypertensive AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 7=================================================================proportion of pts: 0.115827052757lambda: 1791.87941433--------------------------------------------------------------------------------Antidepressive Agents, Second-GenerationCyclooxygenase InhibitorsGABA ModulatorsNAVasodilator Agents===== phenotype 4=================================================================proportion of pts: 0.101943673146lambda: 1783.60672882--------------------------------------------------------------------------------Anesthetics, IntravenousCardiotonic AgentsCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 3=================================================================proportion of pts: 0.0833002776676lambda: 1619.10387137--------------------------------------------------------------------------------Adrenergic beta-1 Receptor AntagonistsAnalgesics, Non-NarcoticCyclooxygenase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsNA===== phenotype 31=================================================================proportion of pts: 0.0864736215787lambda: 1426.4649026--------------------------------------------------------------------------------Analgesics, Non-NarcoticAnti-Allergic AgentsAnti-Bacterial AgentsNAProton Pump Inhibitors===== phenotype 41=================================================================proportion of pts: 0.0654502181674lambda: 1362.81916426--------------------------------------------------------------------------------Anti-Allergic AgentsAnti-Bacterial AgentsBone Density Conservation AgentsCyclooxygenase InhibitorsNAProton Pump Inhibitors===== phenotype 22=================================================================proportion of pts: 0.0836969456565lambda: 1316.62233914--------------------------------------------------------------------------------Analgesics, Non-NarcoticCyclooxygenase InhibitorsNAProton Pump Inhibitors